Clinical trials
Recruiting Phase 1 trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 12 |
| 2024 | 20 |
| 2025 | 30 |
| 2026 | 37 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 115 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 16 |
| AbbVie | 8 |
| Novartis Pharmaceuticals | 8 |
| Daiichi Sankyo | 6 |
| Chugai Pharmaceutical | 5 |
| Amgen | 4 |
| GlaxoSmithKline | 4 |
| Kyowa Kirin Co., Ltd. | 4 |
| BeOne Medicines | 3 |
| Boehringer Ingelheim | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 20 |
| Neoplasms | 13 |
| Colorectal Neoplasms | 11 |
| Neoplasm Metastasis | 11 |
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Triple Negative Breast Neoplasms | 9 |
| Stomach Neoplasms | 8 |
| Breast Neoplasms | 7 |
| Ovarian Neoplasms | 7 |
| Endometrial Neoplasms | 6 |
Trials
Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.